| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1264035
[patent_doc_number] => 06660474
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-09
[patent_title] => 'G protein-related kinase mutants in essential hypertension'
[patent_app_type] => B1
[patent_app_number] => 09/614748
[patent_app_country] => US
[patent_app_date] => 2000-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19088
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/660/06660474.pdf
[firstpage_image] =>[orig_patent_app_number] => 09614748
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/614748 | G protein-related kinase mutants in essential hypertension | Jul 11, 2000 | Issued |
Array
(
[id] => 1414039
[patent_doc_number] => 06525030
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Gene delivery to periosteal cells by microneedle injection'
[patent_app_type] => B1
[patent_app_number] => 09/614178
[patent_app_country] => US
[patent_app_date] => 2000-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9880
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525030.pdf
[firstpage_image] =>[orig_patent_app_number] => 09614178
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/614178 | Gene delivery to periosteal cells by microneedle injection | Jul 10, 2000 | Issued |
Array
(
[id] => 975354
[patent_doc_number] => 06933150
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-23
[patent_title] => 'Relationship of ABC transport proteins with hematopoietic stem cells and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/584586
[patent_app_country] => US
[patent_app_date] => 2000-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 55
[patent_no_of_words] => 31373
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/933/06933150.pdf
[firstpage_image] =>[orig_patent_app_number] => 09584586
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/584586 | Relationship of ABC transport proteins with hematopoietic stem cells and methods of use thereof | May 30, 2000 | Issued |
Array
(
[id] => 1253213
[patent_doc_number] => 06670195
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Mutant genes in Familial British Dementia and Familial Danish Dementia'
[patent_app_type] => B1
[patent_app_number] => 09/579012
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 27497
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670195.pdf
[firstpage_image] =>[orig_patent_app_number] => 09579012
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/579012 | Mutant genes in Familial British Dementia and Familial Danish Dementia | May 25, 2000 | Issued |
Array
(
[id] => 7964455
[patent_doc_number] => 06680199
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-20
[patent_title] => 'In vitro activation of mammalian oocytes'
[patent_app_type] => B1
[patent_app_number] => 09/576592
[patent_app_country] => US
[patent_app_date] => 2000-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 9122
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680199.pdf
[firstpage_image] =>[orig_patent_app_number] => 09576592
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/576592 | In vitro activation of mammalian oocytes | May 21, 2000 | Issued |
Array
(
[id] => 956052
[patent_doc_number] => 06955802
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-10-18
[patent_title] => 'Homeodomain protein code specifying progenitor cell identify and neuronal fate in the ventral neural tube'
[patent_app_type] => utility
[patent_app_number] => 09/569259
[patent_app_country] => US
[patent_app_date] => 2000-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17199
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/955/06955802.pdf
[firstpage_image] =>[orig_patent_app_number] => 09569259
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/569259 | Homeodomain protein code specifying progenitor cell identify and neuronal fate in the ventral neural tube | May 10, 2000 | Issued |
| 09/568255 | Model systems for neurodegenerative and cardiovascular disorders | May 9, 2000 | Abandoned |
| 09/565339 | Generation of human neural crest stem cell line and its utilization in human transplantation | May 4, 2000 | Abandoned |
Array
(
[id] => 1326649
[patent_doc_number] => 06599744
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-29
[patent_title] => 'Viral expression vectors comprising a ribosomal promoter sequence'
[patent_app_type] => B1
[patent_app_number] => 09/562616
[patent_app_country] => US
[patent_app_date] => 2000-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8644
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599744.pdf
[firstpage_image] =>[orig_patent_app_number] => 09562616
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/562616 | Viral expression vectors comprising a ribosomal promoter sequence | Apr 30, 2000 | Issued |
Array
(
[id] => 1073927
[patent_doc_number] => 06838592
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-04
[patent_title] => 'Methods for the identification of compounds for the treatment of alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 09/560124
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10366
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838592.pdf
[firstpage_image] =>[orig_patent_app_number] => 09560124
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/560124 | Methods for the identification of compounds for the treatment of alzheimer's disease | Apr 27, 2000 | Issued |
Array
(
[id] => 637903
[patent_doc_number] => 07125856
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-24
[patent_title] => 'Angiogenic growth factors for treatment of peripheral neuropathy'
[patent_app_type] => utility
[patent_app_number] => 09/546733
[patent_app_country] => US
[patent_app_date] => 2000-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 21611
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125856.pdf
[firstpage_image] =>[orig_patent_app_number] => 09546733
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/546733 | Angiogenic growth factors for treatment of peripheral neuropathy | Apr 10, 2000 | Issued |
Array
(
[id] => 1562675
[patent_doc_number] => 06362392
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-26
[patent_title] => 'Nude mouse model for the growth and treatment of human neurally-derived tumors'
[patent_app_type] => B1
[patent_app_number] => 09/546234
[patent_app_country] => US
[patent_app_date] => 2000-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 12499
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/362/06362392.pdf
[firstpage_image] =>[orig_patent_app_number] => 09546234
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/546234 | Nude mouse model for the growth and treatment of human neurally-derived tumors | Apr 9, 2000 | Issued |
| 09/542537 | Methods for detecting plaques in vivo | Apr 3, 2000 | Abandoned |
| 09/486776 | METHOD OF INDUCING APOPTOSIS IN HUMAN BRAIN TUMOR CELLS USING TRKA RECEPTOR | Mar 28, 2000 | Abandoned |
Array
(
[id] => 1473131
[patent_doc_number] => 06387369
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Cardiac muscle regeneration using mesenchymal stem cells'
[patent_app_type] => B1
[patent_app_number] => 09/446952
[patent_app_country] => US
[patent_app_date] => 2000-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3601
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387369.pdf
[firstpage_image] =>[orig_patent_app_number] => 09446952
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446952 | Cardiac muscle regeneration using mesenchymal stem cells | Mar 26, 2000 | Issued |
Array
(
[id] => 1056091
[patent_doc_number] => 06855314
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-15
[patent_title] => 'AAV5 vector for transducing brain cells and lung cells'
[patent_app_type] => utility
[patent_app_number] => 09/533427
[patent_app_country] => US
[patent_app_date] => 2000-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 51
[patent_no_of_words] => 26105
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/855/06855314.pdf
[firstpage_image] =>[orig_patent_app_number] => 09533427
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/533427 | AAV5 vector for transducing brain cells and lung cells | Mar 21, 2000 | Issued |
Array
(
[id] => 1543804
[patent_doc_number] => 06372955
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Methods for Producing B cells and antibodies from H2-O modified transgenic mice'
[patent_app_type] => B1
[patent_app_number] => 09/516390
[patent_app_country] => US
[patent_app_date] => 2000-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 12144
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372955.pdf
[firstpage_image] =>[orig_patent_app_number] => 09516390
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/516390 | Methods for Producing B cells and antibodies from H2-O modified transgenic mice | Feb 29, 2000 | Issued |
Array
(
[id] => 7625462
[patent_doc_number] => 06723707
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-20
[patent_title] => 'Use of insulin-like growth factor-I in muscle'
[patent_app_type] => B1
[patent_app_number] => 09/510268
[patent_app_country] => US
[patent_app_date] => 2000-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 10939
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723707.pdf
[firstpage_image] =>[orig_patent_app_number] => 09510268
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/510268 | Use of insulin-like growth factor-I in muscle | Feb 21, 2000 | Issued |
Array
(
[id] => 1416378
[patent_doc_number] => 06511958
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-28
[patent_title] => 'Compositions for regeneration and repair of cartilage lesions'
[patent_app_type] => B1
[patent_app_number] => 09/505209
[patent_app_country] => US
[patent_app_date] => 2000-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 31531
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/511/06511958.pdf
[firstpage_image] =>[orig_patent_app_number] => 09505209
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/505209 | Compositions for regeneration and repair of cartilage lesions | Feb 15, 2000 | Issued |
Array
(
[id] => 1189046
[patent_doc_number] => 06734173
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-11
[patent_title] => 'HSP DNA vaccines'
[patent_app_type] => B1
[patent_app_number] => 09/501097
[patent_app_country] => US
[patent_app_date] => 2000-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 27
[patent_no_of_words] => 20872
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734173.pdf
[firstpage_image] =>[orig_patent_app_number] => 09501097
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/501097 | HSP DNA vaccines | Feb 8, 2000 | Issued |